Caris Life Sciences Inc. Registered Shares Cl. A o.N.
- BID
13.8
- ASK
13.9
- 2,039 Units2,249 Units
- 07/21, 11:17:17 AM
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
-
Market Cap
-
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-1.69 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 13.8 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 11:17:17 AM | |
| DAILY VOLUME (UNITS) | 1 | |
| DAILY HIGH / LOW | 13.8 | 13.6 |
| PREV. DAY'S PRICE | 13.6 | (07/20) |
| CHANGE DAY BEFORE | +0.20 | 1.47 % |
| 52 WEEK HIGH / LOW | (-) | (-) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | -1.52 | -1.24 | -1.69 | 0.10 | 0.35 |
DIVIDENDS PER SHARE | - | - | 0.00 | 0.00 | 0.00 |
DIVIDEND YIELD IN % | - | - | 0.00 % | - | - |
DIVIDEND GROWTH IN % | - | - | - | - | - |
PRICE - EARNINGS RATIO | - | - | - | 137.42 | 41.23 |
PRICE - BOOK RATIO | - | - | 13.20 | - | - |
PRICE - SALES RATIO | - | - | 9.39 | - | - |
PRICE - CASH FLOW RATIO | - | - | 101.03 | - | - |
Master Data
| WKN | A41A14 |
| ISIN | US1421521071 |
| SYMBOL | 49J |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | CARIS LIFE SCIEN. A O.N. |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -8.11 % | -14.47 % | -24.44 % | -39.29 % | - | - | - | -42.37 % |
| HIGH | 15.50 | 17.10 | 18.70 | 22.80 | - | - | - | 24.80 |
| LOW | 13.60 | 13.60 | 12.10 | 12.10 | - | - | - | 12.10 |
Dividende
pro Aktie
CARIS LIFE SCIEN. A O.N. does not deliver dividend information
Company profile
Caris Life Sciences, Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring, and precision medicine enabling aspects. It offers services throughout the U.S., Europe, Australia and other international markets. The company was founded by David D. Halbert in 2008 and is headquartered in Irving, TX.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.